Literature DB >> 3226760

Dose-dependent inhibition by naloxone of nociceptive activity evoked in the rat thalamus.

Ilmar Jurna1.   

Abstract

The opiate antagonist naloxone has been reported to cause pain relief. Therefore, the effect was determined of naloxone, injected intravenously, on the activity in single neurones of the dorsomedial part of the ventral nucleus (VDM) in the thalamus of rats under urethane anaesthesia elicited by electrical stimulation of nociceptive afferents in the sural nerve. Naloxone inhibited evoked nociceptive activity in a dose-dependent manner. High doses (5 mg/kg and 1 mg/kg) either increased or reduced the activity, inhibition prevailing at the lower dose. At lower doses (0.5 mg/kg, 0.2 mg/kg and 0.1 mg/kg), naloxone caused only inhibition, the ED50 being 0.36 mg/kg. The (+)-isomer of naloxone (0.2 mg/kg and 2 mg/kg) was ineffective, indicating that the effects of naloxone, which is the (-)-isomer, are stereospecific. The opposing effects exerted by naloxone at high and low doses may be due to the processing of nociceptive messages delivered to the thalamus by multiple endogenous opioid systems with differing susceptibility to naloxone. The results present evidence that naloxone at low doses may cause relief in particular conditions of pain.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3226760     DOI: 10.1016/0304-3959(88)90144-3

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  4 in total

Review 1.  Opioid receptors and pain.

Authors:  R Dirksen
Journal:  Pharm Weekbl Sci       Date:  1990-04-27

2.  Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states.

Authors:  Joshua W Little; Amanda Ford; Ashley M Symons-Liguori; Zhoumou Chen; Kali Janes; Timothy Doyle; Jennifer Xie; Livio Luongo; Dillip K Tosh; Sabatino Maione; Kirsty Bannister; Anthony H Dickenson; Todd W Vanderah; Frank Porreca; Kenneth A Jacobson; Daniela Salvemini
Journal:  Brain       Date:  2014-11-19       Impact factor: 13.501

3.  Sphingosine-1-phosphate receptor 1 activation in astrocytes contributes to neuropathic pain.

Authors:  Zhoumou Chen; Timothy M Doyle; Livio Luongo; Tally M Largent-Milnes; Luigino Antonio Giancotti; Grant Kolar; Silvia Squillace; Serena Boccella; John K Walker; Alexander Pendleton; Sarah Spiegel; William L Neumann; Todd W Vanderah; Daniela Salvemini
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-08       Impact factor: 11.205

4.  A preclinical physiological assay to test modulation of knee joint pain in the spinal cord: effects of oxycodone and naproxen.

Authors:  Jason A Miranda; Phil Stanley; Katrina Gore; Jamie Turner; Rebecca Dias; Huw Rees
Journal:  PLoS One       Date:  2014-08-26       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.